Asia FX weakens slightly, rupee recovers from record low as RBI holds rates
Lake Street Capital Markets assumed coverage of Alphatec Holdings (NASDAQ:ATEC) with a buy rating and set an $18.00 price target on Monday, representing a significant upside from the current trading price of $11.00. According to InvestingPro data, analyst targets for ATEC range from $11.00 to $22.50, with a strong consensus recommendation of 1.7 (Buy).
The research firm cited the company’s focused approach in the spine treatment sector as a key factor in its investment recommendation.
Lake Street noted that Alphatec "represents the only scaled spine player totally focused on improving spine outcomes while much of the industry borders on totally confused."
The coverage initiation followed a non-deal roadshow in New York City where Lake Street analysts met with Alphatec’s management team to discuss the company’s strategy and outlook.
Based on the company’s specialized focus in spine treatments, Lake Street expects "the company’s outsized growth rates will continue" in the coming periods.
In other recent news, Alphatec Holdings Inc. reported its first-quarter 2025 financial results, revealing a mixed performance. The company missed earnings per share (EPS) expectations, reporting -$0.35 compared to the anticipated -$0.12. However, Alphatec’s revenue slightly exceeded forecasts, reaching $169 million against the expected $167.98 million. Despite the earnings miss, the company’s surgical revenue grew by 24% year-over-year, contributing to a total revenue growth of 22%. The company’s adjusted EBITDA was reported at $11 million with a 6% margin. Alphatec also announced its full-year 2025 revenue guidance of $734 million, representing a 20% growth. The company plans to become cash flow positive by the end of the year and projects an adjusted EBITDA of $78 million. Notably, Alphatec continues to expand internationally, with a focus on markets like Australia, New Zealand, and Japan.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.